News
The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by ...
US firms have been on top of the lateral hiring market and performed strongly in Managing IP's Americas Awards and the IP ...
Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...
You also need to talk to a health professional to check that it is suitable. A protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna jabs, is also available.
Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...
Pfizer and Flagship Pioneering are ... potential lupus asset for Flagship’s Pioneering Medicines Valo Health now marks the sixth collaboration for the $7 billion biobucks, 10-program ...
Collaboration leverages Logica, a platform offering from Valo Health and Charles River that ... partnership between Flagship Pioneering and Pfizer to accelerate discovery of innovative compounds ...
The UK Health and Security Agency last week published early data, opens new tab from the roll out in 2024 of Pfizer's vaccine in England, showing that the shot is making a significant reduction to ...
The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S ...
the result of a strategic collaboration between Charles River and Valo Health, is the industry’s first computation-powered, unified target-to-candidate offering. The platform leverages the ...
Importance of Charles River and Valo’s Combined Offering Logica, the result of a strategic collaboration between Charles River and Valo Health, is the industry’s first computation-powered, unified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results